Simrat Randhawa
EVP, Head of R&D · 4 filings · Latest: Sep 1, 2026
Dianthus Therapeutics, Inc. /DE/
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DNTH | Simrat Randhawa | EVP, Head of R&D | Sep 1, 2026 | Sale | $106.41 | 23,124 | $2.5M | 4,000 | |
DNTH | Simrat Randhawa | EVP, Head of R&D | Sep 1, 2026 | Option Exercise | $20.63 | 23,124 | $477.0K | 27,124 | |
DNTH | SIMRAT RANDHAWA | — | Sep 1, 2026 | Proposed Sale | $105.61 | 23,124 | $2.4M | — | |
DNTH | Simrat Randhawa | EVP, Head of R&D | Jun 1, 2026 | Sale | $90.62 | 26,530 | $2.4M | 4,000 | |
DNTH | Simrat Randhawa | EVP, Head of R&D | Jun 1, 2026 | Option Exercise | $18.85 | 26,530 | $500.2K | 30,530 | |
DNTH | SIMRAT RANDHAWA | — | Jun 1, 2026 | Proposed Sale | $93.01 | 26,530 | $2.5M | — | |
DNTH | Simrat Randhawa | EVP, Head of R&D | Mar 12, 2026 | Sale | $81.48 | 33,830 | $2.8M | 0 | |
DNTH | Simrat Randhawa | EVP, Head of R&D | Mar 12, 2026 | Option Exercise | $18.15 | 33,830 | $614.2K | 33,830 | |
DNTH | SIMRAT RANDHAWA | — | Mar 12, 2026 | Proposed Sale | $85.84 | 33,830 | $2.9M | — | |
DNTH | SIMRAT RANDHAWA | — | Nov 13, 2025 | Proposed Sale | $38.72 | 196,538 | $7.6M | — |